Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guilong Pharmaceutical
Ma'anshan, Anhui, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Guilong Pharmaceutical is a leading provider of OTC and TCM-based treatments for throat and upper respiratory conditions in China, with flagship products including Manyanshuning. Its main TCM products are widely approved and commercialized in China for cough and bronchitis, with evidence of continued market leadership and clinical use[2][3][4][5].
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Herbal medicine
- Industry
- Biotech
02
Partnerships
Reckitt Benckiser (prior acquisition/investment for Chinese base)[1][3]Trustar Capital (current controlling investor/parent)[4][5]
Beyond the preview
Go deeper on Guilong Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guilong Pharmaceutical.